HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Limited protective effect of rough mutant antisera in murine Escherichia coli bacteremia.

Abstract
Previous studies in mice have demonstrated differing immunoprophylactic activity of antisera against rough mutants of Enterobacteriaceae in the prevention of lethal gram-negative bacteremia. In this study, in which CF1 mice were made bacteremic with a serum-resistant Escherichia coli 06:K2:H1, the composite survival was significantly (p less than 0.001) enhanced by i. v. pre-treatment one to two hours before injection with either normal rabbit sera or antisera to the J5 mutant of E. coli 0111. The protective efficacy of these preimmune and hyperimmune sera did not differ significantly. Since considerable variability in the mortality of control mice occurred in the 25 separate experiments, the results of individual experiments were grouped retrospectively according to survival in the individual control groups and compared for evidence of possible differences in the efficacy of these two sera. With the exception of a statistically significant difference in the efficacy in one group receiving an LD75-95 inoculum, no such differences were noted. Thus, the variable effects of a rough mutant antiserum were not explained by differences in the relative virulence in the inoculum. This study confirms earlier observations by others that the protective efficacy of the anti-J5 antisera in infected mice does not differ appreciably from that of normal rabbit sera, provided the same donor rabbits are the source of both preimmune and hyperimmune sera.
AuthorsG Peter, M Chernow, M H Keating, J C Ryff, S H Zinner
JournalInfection (Infection) Vol. 10 Issue 4 Pg. 228-32 ( 1982) ISSN: 0300-8126 [Print] Germany
PMID6752035 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antigens, Bacterial
Topics
  • Animals
  • Antigens, Bacterial (immunology)
  • Escherichia coli (genetics, immunology)
  • Escherichia coli Infections (prevention & control)
  • Female
  • Immunization, Passive
  • Mice
  • Mutation
  • Sepsis (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: